Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Figure S7 from A Genome-Wide Synthetic Lethal Screen Identifies Spermidine Synthase as a Target to Enhance Erdafitinib Efficacy in FGFR-Mutant Bladder Cancer
Home
Publications
Figure S7 from A Genome-Wide Synthetic Lethal Screen Identifies Spermidine Synthase as a Target to Enhance Erdafitinib Efficacy in FGFR-Mutant Bladder Cancer
Figure S7 from A Genome-Wide Synthetic Lethal Screen Identifies Spermidine Synthase as a Target to Enhance Erdafitinib Efficacy in FGFR-Mutant Bladder Cancer
Authors:
YY
Yanchao Yu
Yanchao Yu
XG
Xincheng Gao
Xincheng Gao
HZ
Huayuan Zhao
Huayuan Zhao
JS
Jiayin Sun
Jiayin Sun
MW
Miao Wang
Miao Wang
XX
Xing Xiong
Xing Xiong
JL
Junping Li
Junping Li
CH
Chao Huang
Chao Huang
HZ
Hui Zhang
Hui Zhang
GJ
Guosong Jiang
Guosong Jiang
XX
Xingyuan Xiao
Xingyuan Xiao
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
16 June 2025
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/0008-5472.29326824
Abstract
Figure. S7 shows that SRM inhibitor MCHA is synthetic lethal with Erdafitinib.
Keywords
SCREEN IDENTIFIES
IDENTIFIES SPERMIDINE
SPERMIDINE SYNTHASE
BLADDER CANCER
CANCER FIGURE
FGFR-MUTANT BLADDER
ENHANCE ERDAFITINIB
ERDAFITINIB EFFICACY
LETHAL SCREEN
SYNTHETIC LETHAL
Related articles
Scroll to top